Jordan A. Greco

Chief Scientific Officer at LambdaVision

Dr. Jordan Greco obtained his PhD in Physical Chemistry at the University of Connecticut. Under the direction of Dr. Robert Birge, Jordan focused his graduate thesis work primarily on the investigation of the structure and function of photoactive proteins, using both spectroscopic and quantum mechanical approaches. Much of his work has contributed toward the application of the light-activated protein, bacteriorhodopsin into photonic and biomimetic devices, such as protein-based optical memories and processors, photovoltaic cells, and the protein-based artificial retina being developed by LambdaVision.

Jordan's graduate thesis work influenced the design and development of the artificial retina construct and the production techniques that are used to produce the treatment. Moreover, his research efforts helped to direct critical proof-of-concept experiments that investigated the efficacy of the artificial retina architecture. As CSO, Jordan is responsible for the production of the artificial retinas, establishing standard operating procedures and quality control measures, and commercialization efforts.

Concurrent with his work on bacteriorhodopsin, Jordan has contributed to numerous computational analyses for the excited-state behavior of heterocyclic-conjugated compounds (e.g., porphyrin, chlorins, and corroles), carotenoids (e.g., peridinin), and other polyene-based chromophores rooted in biological systems. Jordan has presented this work to international audiences and he continues to remain active in the field via several multidisciplinary collaborations.

Links

Timeline

  • Chief Scientific Officer

    2010 - present